Isoetharine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for isoetharine hydrochloride and what is the scope of freedom to operate?
Isoetharine hydrochloride
is the generic ingredient in four branded drugs marketed by Nephron, Sanofi Aventis Us, Alpharma Us Pharms, Astrazeneca, Baxter Hlthcare, DEY, Intl Medication, Parke Davis, and Roxane, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for isoetharine hydrochloride.
Summary for isoetharine hydrochloride
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 9 |
NDAs: | 35 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Patent Applications: | 514 |
DailyMed Link: | isoetharine hydrochloride at DailyMed |
US Patents and Regulatory Information for isoetharine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | ISOETHARINE HYDROCHLORIDE | isoetharine hydrochloride | SOLUTION;INHALATION | 089616-001 | Jun 13, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dey | ISOETHARINE HYDROCHLORIDE S/F | isoetharine hydrochloride | SOLUTION;INHALATION | 089252-001 | Sep 15, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dey | ISOETHARINE HYDROCHLORIDE S/F | isoetharine hydrochloride | SOLUTION;INHALATION | 089820-001 | Nov 22, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | ISOETHARINE HYDROCHLORIDE | isoetharine hydrochloride | SOLUTION;INHALATION | 088470-001 | Mar 14, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |